[go: up one dir, main page]

CN116410942B - Prephenate dehydrogenase SaPD and its encoding gene and application - Google Patents

Prephenate dehydrogenase SaPD and its encoding gene and application Download PDF

Info

Publication number
CN116410942B
CN116410942B CN202310197550.6A CN202310197550A CN116410942B CN 116410942 B CN116410942 B CN 116410942B CN 202310197550 A CN202310197550 A CN 202310197550A CN 116410942 B CN116410942 B CN 116410942B
Authority
CN
China
Prior art keywords
sapd
protein
tyrosine
sequence
prephenate dehydrogenase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202310197550.6A
Other languages
Chinese (zh)
Other versions
CN116410942A (en
Inventor
李静
刘建国
张海林
翟永年
公辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
China University of Petroleum East China
Original Assignee
China University of Petroleum East China
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by China University of Petroleum East China filed Critical China University of Petroleum East China
Priority to CN202310197550.6A priority Critical patent/CN116410942B/en
Publication of CN116410942A publication Critical patent/CN116410942A/en
Application granted granted Critical
Publication of CN116410942B publication Critical patent/CN116410942B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/001Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y103/00Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/01Oxidoreductases acting on the CH-CH group of donors (1.3) with NAD+ or NADP+ as acceptor (1.3.1)
    • C12Y103/01012Prephenate dehydrogenase (1.3.1.12)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185Escherichia
    • C12R2001/19Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

The invention discloses prephenate dehydrogenase SaPD, and a coding gene and application thereof. The protein provided by the invention is derived from helicobacter salis (Salinispirillum sp.) and is named SaPD protein, and is composed of an amino acid sequence shown as a sequence 1 in a sequence table. The invention also protects the application of SaPD protein as prephenate dehydrogenase.

Description

预苯酸脱氢酶SaPD及其编码基因和应用Prephenate dehydrogenase SaPD and its encoding gene and application

技术领域Technical Field

本发明属于生物技术领域,具体涉预苯酸脱氢酶SaPD及其编码基因和应用。The invention belongs to the field of biotechnology, and in particular relates to prephenate dehydrogenase SaPD and a coding gene and application thereof.

背景技术Background technique

L-酪氨酸是一种芳香族氨基酸,是生物体重要的条件必需氨基酸,对人和动物的生长发育和新陈代谢起重要的作用,是婴幼儿和苯丙酮尿症患者重要的外源营养补充剂,广泛应用于食品、饲料行业。在医药领域,L-酪氨酸可以改善记忆力,抵抗抑郁和焦虑,是帕金森氏病药物3,4-二羟基-L-苯丙氨酸(L-DOPA)的重要前体,也是合成L-多巴、甲状腺素、肾上腺素、酪氨酸亚硫酸盐等高附加值药物的前体。在化工行业中,L-酪氨酸是对羟基肉桂酸、对羟基苯乙烯等产品的制备原料。L-Tyrosine is an aromatic amino acid and an important conditionally essential amino acid for organisms. It plays an important role in the growth, development and metabolism of humans and animals. It is an important exogenous nutritional supplement for infants and children and patients with phenylketonuria. It is widely used in the food and feed industries. In the pharmaceutical field, L-Tyrosine can improve memory, resist depression and anxiety, and is an important precursor of the Parkinson's disease drug 3,4-dihydroxy-L-phenylalanine (L-DOPA). It is also a precursor for the synthesis of high-value-added drugs such as L-DOPA, thyroxine, adrenaline, and tyrosine sulfite. In the chemical industry, L-Tyrosine is a raw material for the preparation of products such as p-hydroxycinnamic acid and p-hydroxystyrene.

传统的L-酪氨酸生产主要有化学法、蛋白质水解法、酶法和发酵法。蛋白质水解法存在材料来源受限、工艺和产品复杂、周期长等缺点,已被淘汰。化学法过程繁杂、产物转化率低、环境污染重,尤其是只能合成D、L-型外消旋体,受到了严重制约。Traditional L-tyrosine production mainly includes chemical method, protein hydrolysis method, enzyme method and fermentation method. Protein hydrolysis method has the disadvantages of limited material sources, complex process and products, long cycle, etc., and has been eliminated. The chemical method has complicated process, low product conversion rate, heavy environmental pollution, especially it can only synthesize D and L-type racemates, which is seriously restricted.

微生物发酵法是当前L-酪氨酸主要方法。在微生物体内合成L-酪氨酸的代谢通路中,分支酸作为L-酪氨酸、L-色氨酸和L-苯丙氨酸合成的分支点,三种芳香氨基酸竞争底物。为了提高L-酪氨酸的生产效率,往往要修饰和优化微生物代谢网络和表达调控网络。因此,生产菌株往往要经过诱变处理或代谢工程改造。发酵法生产L-酪氨酸工艺控制也比较复杂,需要满足微生物自身生长和产物积累的双重要求。Microbial fermentation is currently the main method for producing L-tyrosine. In the metabolic pathway for synthesizing L-tyrosine in microorganisms, chorismate serves as a branching point for the synthesis of L-tyrosine, L-tryptophan, and L-phenylalanine, and the three aromatic amino acids compete for substrates. In order to improve the production efficiency of L-tyrosine, it is often necessary to modify and optimize the microbial metabolic network and expression regulation network. Therefore, production strains often have to undergo mutagenesis or metabolic engineering. The process control of producing L-tyrosine by fermentation is also relatively complex, and needs to meet the dual requirements of microbial growth and product accumulation.

生物酶催化专一性强、反应条件温和、条件容易控制,为L-酪氨酸的廉价、高效生产提供了重要的思路,受到越来越多的重视。预苯酸脱氢酶能够催化预苯酸氧化脱羧产生对羟基苯丙酮酸,再经过转氨作用合成L-酪氨酸,是微生物从头和从L-酪氨酸的关键酶,也是体外生产L-酪氨酸的可行途径。但是,目前发现的预苯酸脱氢酶,在催化L-酪氨酸的合成过程中,绝大多数都受到终产物L-酪氨酸的反馈抑制,这在很大程度上限制了L-酪氨酸的产量。必须要通过手段解除酪氨酸对预苯酸脱氢酶的反馈抑制,或者选育高活性和低反馈抑制的新型预苯酸脱氢酶,才能实现对酶法和微生物法生产L-酪氨酸至关重要。Biological enzyme catalysis has strong specificity, mild reaction conditions, and easy control of conditions, which provides an important idea for the cheap and efficient production of L-tyrosine and has received more and more attention. Prephenate dehydrogenase can catalyze the oxidative decarboxylation of prephenate to produce p-hydroxyphenylpyruvate, and then synthesize L-tyrosine through transamination. It is a key enzyme for microbial de novo and L-tyrosine production, and is also a feasible way to produce L-tyrosine in vitro. However, most of the prephenate dehydrogenases discovered so far are subject to feedback inhibition by the end product L-tyrosine during the catalytic synthesis of L-tyrosine, which greatly limits the production of L-tyrosine. It is necessary to remove the feedback inhibition of tyrosine on prephenate dehydrogenase by means of tyrosine, or to breed new prephenate dehydrogenases with high activity and low feedback inhibition, which is crucial to the production of L-tyrosine by enzymatic and microbial methods.

微生物发酵生产L-酪氨酸使用的是来自大肠杆菌、短杆菌、棒杆菌、或基因工程改造菌株的预苯酸脱氢酶,少见来自极端微生物菌株的生物酶。极端酶往往具有更好的pH、温度、盐度适应范围和重金属、有机溶剂、变性剂的耐受性,或者其它来源生物酶所不具备的特征。本发明提供了一种来源于嗜盐碱微生物菌株的预苯酸脱氢酶SaPD及其编码基因,耐受L-酪氨酸,可用于生产条件宽泛,可用于L-酪氨酸的生产。Microbial fermentation to produce L-tyrosine uses prephenate dehydrogenase from Escherichia coli, Brevibacterium, Corynebacterium, or genetically engineered strains, and biological enzymes from extreme microbial strains are rare. Extreme enzymes often have better pH, temperature, salinity adaptability and tolerance to heavy metals, organic solvents, denaturants, or features that biological enzymes from other sources do not have. The present invention provides a prephenate dehydrogenase SaPD derived from a halophilic alkali microbial strain and a coding gene thereof, which is tolerant to L-tyrosine and can be used in a wide range of production conditions and can be used for the production of L-tyrosine.

发明内容Summary of the invention

本发明的目的是提供预苯酸脱氢酶SaPD及其编码基因和应用。The purpose of the present invention is to provide prephenate dehydrogenase SaPD and its encoding gene and application.

本发明提供的蛋白质,来源于盐螺旋菌NM(Salinispirillum sp.NM),是一种预苯酸脱氢酶,命名为SaPD蛋白,氨基酸序列由序列表中序列1所示。由于氨基酸序列的特殊性,任何含有序列表中序列1所示氨基酸序列的肽蛋白的片段或其突变体,只要其与前述氨基酸序列具有99%以上同源性,且具有预苯酸脱氢酶功能,均属于本发明保护范围。具体的,所述改变包括氨基酸序列中一个或几个氨基酸残基的取代和/或缺失和/或添加和/或替换。The protein provided by the present invention is derived from Salinispirillum sp. NM, is a prephenate dehydrogenase, named SaPD protein, and the amino acid sequence is shown in Sequence 1 in the sequence table. Due to the particularity of the amino acid sequence, any fragment or mutant of the peptide protein containing the amino acid sequence shown in Sequence 1 in the sequence table, as long as it has more than 99% homology with the aforementioned amino acid sequence and has the function of prephenate dehydrogenase, belongs to the protection scope of the present invention. Specifically, the change includes substitution and/or deletion and/or addition and/or replacement of one or more amino acid residues in the amino acid sequence.

SaPD蛋白的编码基因也属于本发明的保护范围。The gene encoding the SaPD protein also falls within the protection scope of the present invention.

优选的,所述基因的碱基序列如序列表中序列2所示,该基因序列来源于盐螺旋菌(Salinispirillum sp.),由900个碱基组成。由于核苷酸序列的特殊性,任何序列表中序列2所示多核苷酸的变体,只要其与该多核苷酸具有90%以上同源性,均属于本发明保护范围之列。所述多核苷酸的变体是指一种具有一个或多个核苷酸改变的多核苷酸序列。此多核苷酸的变体包括取代变异体、缺失变异体和插入变异体。Preferably, the base sequence of the gene is shown in Sequence 2 in the sequence table, and the gene sequence is derived from Salinispirillum sp. and consists of 900 bases. Due to the particularity of the nucleotide sequence, any variant of the polynucleotide shown in Sequence 2 in the sequence table, as long as it has more than 90% homology with the polynucleotide, belongs to the scope of protection of the present invention. The variant of the polynucleotide refers to a polynucleotide sequence with one or more nucleotide changes. The variant of this polynucleotide includes substitution variants, deletion variants and insertion variants.

含有所述基因的重组表达载体、表达盒或重组微生物均属于本发明的保护范围。The recombinant expression vector, expression cassette or recombinant microorganism containing the gene all fall within the protection scope of the present invention.

本发明还保护SaPD蛋白作为预苯酸脱氢酶的应用。应用SaPD蛋白作为预苯酸脱氢酶时,采用的温度为25-70℃,采用的pH为3-11。应用SaPD蛋白作为预苯酸脱氢酶时,采用的温度为40℃,采用的pH为8。The present invention also protects the use of SaPD protein as prephenate dehydrogenase. When SaPD protein is used as prephenate dehydrogenase, the temperature used is 25-70°C and the pH used is 3-11. When SaPD protein is used as prephenate dehydrogenase, the temperature used is 40°C and the pH used is 8.

本发明提供的预苯酸脱氢酶具有较高的酶活力和热稳定性,对产物L-酪氨酸的耐受性高,并且反应温度宽泛,反应pH宽泛。The prephenate dehydrogenase provided by the invention has high enzyme activity and thermal stability, high tolerance to the product L-tyrosine, and a wide reaction temperature and a wide reaction pH.

盐螺旋菌NM(Salinispirillum sp.NM)已于2021年4月26日保藏于中国典型培养物保藏中心(地址:中国,武汉,武汉大学;邮编:430072),保藏编号为CCTCC NO:M 2021460。Salinispirillum sp. NM was deposited in the China Center for Type Culture Collection (Address: Wuhan University, Wuhan, China; Postal Code: 430072) on April 26, 2021, with the deposit number CCTCC NO: M 2021460.

附图说明BRIEF DESCRIPTION OF THE DRAWINGS

图1为菌株NM的扫描电镜照片。Figure 1 is a scanning electron micrograph of strain NM.

图2为菌株NM的系统进化树。Figure 2 is a phylogenetic tree of strain NM.

图3为SaPD蛋白质的SDS-APGE电泳图。FIG3 is the SDS-APGE electrophoresis diagram of SaPD protein.

图4为检测最适pH时的相对酶活结果。FIG4 shows the relative enzyme activity results at the optimal pH.

图5为检测最适反应温度时的相对酶活结果。FIG5 shows the relative enzyme activity results when detecting the optimal reaction temperature.

图6为L-酪氨酸对SaPD蛋白质的酶活影响结果。FIG. 6 shows the effect of L-tyrosine on the enzyme activity of SaPD protein.

具体实施方式Detailed ways

以下的实施例便于更好地理解本发明,但并不限定本发明。下述实施例中的实验方法,如无特殊说明,均为常规方法。下述实施例中所用的试验材料,如无特殊说明,均为自常规生化试剂商店购买得到的。以下实施例中的定量试验,均设置三次重复实验,结果取平均值。The following examples are provided for a better understanding of the present invention, but are not intended to limit the present invention. The experimental methods in the following examples are conventional methods unless otherwise specified. The test materials used in the following examples are purchased from conventional biochemical reagent stores unless otherwise specified. The quantitative tests in the following examples were repeated three times, and the results were averaged.

实施例1、盐螺旋菌NM的分离、鉴定和保藏Example 1. Isolation, identification and preservation of Halospira NM

一、分离1. Separation

样品取自内蒙古鄂尔多斯地区的一处碱湖,取碱湖样品50μL,加入碱湖滤液450μL,吹打混匀得到10-1浓度样品,依次稀释得到10-1、10-2、10-3、10-4、10-5浓度的样品。取碱湖水样原液20μL、40μL及稀释得到的样品,涂布到LBH固体培养基中,在35℃恒温培养箱中培养3-4d后,观察生长情况。The sample was taken from an alkaline lake in Ordos, Inner Mongolia. 50 μL of the alkaline lake sample was added to 450 μL of the alkaline lake filtrate, and the sample was mixed by blowing to obtain a 10-1 concentration sample, which was then diluted to obtain samples with concentrations of 10-1 , 10-2 , 10-3 , 10-4 , and 10-5 . 20 μL, 40 μL of the original solution of the alkaline lake water sample and the diluted sample were spread on LBH solid culture medium, and the growth was observed after culturing in a 35°C constant temperature incubator for 3-4 days.

二、鉴定2. Identification

将纯化后的菌株接种至LBH固体培养基中,于30℃恒温培养3d后,记录菌株的菌落颜色、凸起情况、边缘规则性、大小及透明度等。利用透射电子显微镜和倒置荧光显微镜观察菌株的形态、大小和胞外附属物等特征。利用革兰氏染色法对菌株进行革兰氏染色处理,使用倒置荧光显微镜观察细菌的革兰氏染色情况。此外,采用穿刺接种法将菌株接种至半固体LBH培养基中,用以观察细菌的运动性和好氧性情况。The purified strain was inoculated into LBH solid medium and cultured at 30°C for 3 days. The colony color, protrusion, edge regularity, size and transparency of the strain were recorded. The morphology, size and extracellular appendages of the strain were observed using a transmission electron microscope and an inverted fluorescence microscope. The strain was treated with Gram staining and the Gram staining of the bacteria was observed using an inverted fluorescence microscope. In addition, the strain was inoculated into a semi-solid LBH medium using the puncture inoculation method to observe the motility and aerobicity of the bacteria.

以LBH液体培养基作为基础培养基,分别添加0-10.0%浓度(以1%为增量,w/v)的NaCl,将菌株接种至上述培养基中,并于30℃下培养7d,空白对照组为不接种菌株的LBH培养基,利用分光光度计在600nm波长下检测菌体密度,从而确定菌株生长的最佳盐度;在pH3.0-11.0范围内(以1.0单位为间隔),调节LBH液体培养基的pH值,将菌株接种至上述液体培养基中,空白对照组为不接种菌株的LBH培养基,使用分光光度计在600nm波长下检测菌体的生长密度,确定菌株生长的最适pH;将菌株接种至LBH液体培养基中,分别在4℃、10℃、15℃、20℃、25℃、28℃、30℃、37℃、40℃、45℃和50℃下培养7d,空白对照组为不接种菌株的LBH培养基,利用分光光度计在600nm波长下检测菌体的生长密度,从而确定菌株的最适温度及温度生长范围;利用Biolog GEN III鉴定板检测菌株对不同碳源的利用情况。Using LBH liquid medium as the basic medium, 0-10.0% concentration (in increments of 1%, w/v) of NaCl was added respectively, the strain was inoculated into the above medium, and cultured at 30°C for 7 days. The blank control group was LBH medium without inoculation of the strain, and the bacterial density was detected at a wavelength of 600nm using a spectrophotometer to determine the optimal salinity for the growth of the strain; the pH value of the LBH liquid medium was adjusted within the range of pH 3.0-11.0 (in intervals of 1.0 unit), and the strain was inoculated into the above liquid medium. The blank control group was The growth density of the bacteria was detected at a wavelength of 600nm using a spectrophotometer in the LBH medium without inoculation of the strain, so as to determine the optimal pH for the growth of the strain; the strain was inoculated into LBH liquid culture medium and cultured at 4℃, 10℃, 15℃, 20℃, 25℃, 28℃, 30℃, 37℃, 40℃, 45℃ and 50℃ for 7d, respectively; the blank control group was LBH medium without inoculation of the strain, and the growth density of the bacteria was detected at a wavelength of 600nm using a spectrophotometer, so as to determine the optimal temperature and temperature growth range of the strain; the utilization of different carbon sources by the strain was detected using the Biolog GEN III identification plate.

使用API 20NE和API 32GN试剂盒对菌株进行鉴定,如硝酸盐还原试验、亚硝酸盐还原试验、酶活特性及碳源利用试验等。菌株NM和参考菌株Salinispirillum marinumGCWy1T的结果见表1。The strains were identified using API 20NE and API 32GN kits, such as nitrate reduction test, nitrite reduction test, enzyme activity characteristics and carbon source utilization test. The results of strain NM and reference strain Salinispirillum marinumGCWy1 T are shown in Table 1.

表1Table 1

利用基因组提取试剂盒提取菌株的基因组DNA,并利用PCR技术扩增菌株的16SrDNA序列。本实验采用的PCR体系为:4μL模板DNA、1μL引物27F、1μL引物1492R、5μL 10×TaqBuffer、4μL dNTP、0.8μL Taq DNA聚合酶、34.2μL灭菌超纯水。利用琼脂糖凝胶电泳对PCR扩增产物进行验证,若条带大小符合预期实验结果,则将PCR扩增产物送至青岛擎科生物有限公司进行测序。如果测序结果正确,则对PCR扩增产物进行切胶回收,并利用pClone007Simple Vector Kit克隆试剂盒克隆目的条带,再将克隆后的目的基因与质粒pMD18-T连接,最后将重组质粒转入大肠杆菌E.coli DH5α中,转化过程严格按照感受态细胞E.coliDH5α的使用操作说明进行。将测得的16S rDNA序列结果上传至https://www.ezbiocloud.net/网站进行序列对比分析,确定分离细菌的种属,并下载与菌株亲缘性较高的细菌的16S rDNA序列。通过选择合适的外群,并基于分离菌株及其相关菌株的16SrDNA基因序列,使用MEGA 7.0软件构建菌株的系统发育树。使用近邻连接法(NJ)进行细菌的系统发育分析。基于1000次重复,使用Bootstrap分析确定系统发生树的拓扑结构。系统进化树见图2。The genomic DNA of the strain was extracted using a genome extraction kit, and the 16SrDNA sequence of the strain was amplified using PCR technology. The PCR system used in this experiment was: 4μL template DNA, 1μL primer 27F, 1μL primer 1492R, 5μL 10×TaqBuffer, 4μL dNTP, 0.8μL Taq DNA polymerase, and 34.2μL sterilized ultrapure water. The PCR amplification product was verified by agarose gel electrophoresis. If the band size was consistent with the expected experimental results, the PCR amplification product was sent to Qingdao Qingke Biological Co., Ltd. for sequencing. If the sequencing results were correct, the PCR amplification product was excised and recovered, and the target band was cloned using the pClone007Simple Vector Kit cloning kit, and the cloned target gene was connected to the plasmid pMD18-T. Finally, the recombinant plasmid was transferred into E. coli DH5α. The transformation process was strictly carried out in accordance with the instructions for use of the competent cell E. coli DH5α. The measured 16S rDNA sequence results were uploaded to https://www.ezbiocloud.net/ for sequence comparison analysis, to determine the species of the isolated bacteria, and to download the 16S rDNA sequences of bacteria with a high affinity to the strains. By selecting a suitable outgroup and based on the 16SrDNA gene sequences of the isolated strains and their related strains, the phylogenetic tree of the strains was constructed using MEGA 7.0 software. The phylogenetic analysis of bacteria was performed using the neighbor joining method (NJ). Based on 1000 repetitions, the topological structure of the phylogenetic tree was determined using Bootstrap analysis. The phylogenetic tree is shown in Figure 2.

以上鉴定结果表明,菌株NM属于糖螺旋菌科(Saccharospirillaceae),盐螺旋菌属(Salinispirillum)。The above identification results showed that strain NM belonged to the family Saccharospirillaceae and the genus Salinispirillum.

三、保藏3. Preservation

盐螺旋菌NM(Salinispirillum sp.NM)已于2021年4月26日保藏于中国典型培养物保藏中心(地址:中国,武汉,武汉大学;邮编:430072),保藏编号为CCTCC NO:M 2021460。Salinispirillum sp. NM was deposited in the China Center for Type Culture Collection (Address: Wuhan University, Wuhan, China; Postal Code: 430072) on April 26, 2021, with the deposit number CCTCC NO: M 2021460.

实施例2、预苯酸脱氢酶(SaPD蛋白)的制备Example 2. Preparation of prephenate dehydrogenase (SaPD protein)

经过大量序列分析、比对和功能验证,从盐螺旋菌NM中发现一个新蛋白,将其命名为SaPD蛋白,如序列表的序列1所示。将盐螺旋菌NM中编码SaPD蛋白的基因命名为SaPD基因,其编码框如序列表的序列2所示。After a large number of sequence analyses, alignments and functional verifications, a new protein was found from Halospirillum NM, which was named SaPD protein, as shown in Sequence 1 of the sequence listing. The gene encoding SaPD protein in Halospirillum NM was named SaPD gene, and its coding frame was shown in Sequence 2 of the sequence listing.

一、构建重组质粒1. Construction of recombinant plasmid

1、以盐螺旋菌NM的基因组DNA为模板,采用PD-F和PD-R组成的引物对进行PCR扩增,回收PCR扩增产物。1. Using the genomic DNA of Halspirillum NM as a template, PCR amplification was performed using a primer pair consisting of PD-F and PD-R, and the PCR amplification product was recovered.

PD-F:5’-CCGGAATTCATGATCAATCAAGCG-3’;PD-F: 5'- CCGG AATTCATGATCAATCAAGCG-3';

PD-R:5’-CCCAAGCTTTTACCTGGAACGTTCT-3’。PD-R: 5’-CCCAAGCTTTTACCTGGAACGTTCT-3’.

2、取步骤1得到的PCR扩增产物,与pET-28a载体连接,得到重组质粒pET-28a-SaPD。2. Take the PCR amplification product obtained in step 1 and connect it with the pET-28a vector to obtain the recombinant plasmid pET-28a-SaPD.

pET-28a载体(pET-28a Vector):安诺伦(北京)生物科技有限公司,产品目录号69864-3。pET-28a Vector: Anolun (Beijing) Biotechnology Co., Ltd., product catalog number 69864-3.

经测序,重组质粒pET-28a-SaPD中具有序列表的序列2所示的DNA分子。After sequencing, the recombinant plasmid pET-28a-SaPD contained the DNA molecule shown in Sequence 2 of the sequence listing.

二、制备重组菌2. Preparation of recombinant bacteria

将重组质粒pET-28a-SaPD导入大肠杆菌BL21(DE3),得到重组菌甲。The recombinant plasmid pET-28a-SaPD was introduced into Escherichia coli BL21 (DE3) to obtain recombinant bacteria A.

将pET-28a载体导入大肠杆菌BL21(DE3),得到重组菌乙。The pET-28a vector was introduced into Escherichia coli BL21 (DE3) to obtain recombinant bacteria B.

三、表达蛋白3. Protein Expression

1、将重组菌接种至含50μg/mL卡那霉素的液体LB培养基,37℃、150rpm振荡培养12小时,得到种子液。1. Inoculate the recombinant bacteria into liquid LB medium containing 50 μg/mL kanamycin, and culture at 37°C and 150 rpm for 12 hours to obtain seed solution.

2、将1体积份种子液接种至99体积份含50μg/mL卡那霉素的液体LB培养基中,37℃、200rpm振荡培养至OD600nm值约为0.6,此时加入IPTG诱导剂并使其在体系中的浓度为0.5mmol/L,然后25℃、200rpm振荡培养6h(诱导表达),然后4℃、8000×g离心10min,收集菌体沉淀。2. Inoculate 1 volume of seed liquid into 99 volumes of liquid LB medium containing 50 μg/mL kanamycin, and culture at 37°C and 200 rpm with shaking until the OD 600nm value is about 0.6. At this time, add IPTG inducer and make its concentration in the system 0.5 mmol/L, then culture at 25°C and 200 rpm with shaking for 6 h (induced expression), then centrifuge at 4°C and 8000×g for 10 min, and collect the bacterial precipitate.

3、取步骤2得到的沉淀,用Tris-HCl缓冲液(0.05M,pH 7.4)洗涤,然后悬浮于Tris-HCl缓冲液(0.05M,pH 7.2)并进行超声破碎(超声破碎参数:功率200W,每超声4s停6s,总时间为40min),然后4℃、10000×g离心20min,收集上清液。3. Take the precipitate obtained in step 2, wash it with Tris-HCl buffer (0.05M, pH 7.4), then suspend it in Tris-HCl buffer (0.05M, pH 7.2) and perform ultrasonic disruption (ultrasonic disruption parameters: power 200W, 4s of ultrasound and 6s of pause, total time 40min), then centrifuge at 4°C, 10000×g for 20min, and collect the supernatant.

重组菌甲进行上述步骤得到的上清液,命名为粗酶液甲。The supernatant obtained by carrying out the above steps on the recombinant bacteria A is named crude enzyme solution A.

重组菌乙进行上述步骤得到的上清液,命名为粗酶液乙。The supernatant obtained by carrying out the above steps with the recombinant bacteria B is named crude enzyme solution B.

四、纯化蛋白4. Protein Purification

取步骤三得到的粗酶液甲,用孔径为0.22μm的微滤滤膜过滤,收集滤液。取滤液,采用SuperdexTM 200 10/60凝胶层析柱进行分离纯化。将SuperdexTM 20010/60凝胶层析柱连接到快速蛋白液相系统,以1×PBS缓冲液(pH 8.0)作为流动相,流速为0.5mL/min。收集保留体积为18-20mL对应洗脱峰的过柱后溶液,即为SaPD蛋白溶液。SaPD蛋白溶液的电泳图见图3,仅一条蛋白带,且符合预估分子量(约33.2KD)。Take the crude enzyme solution A obtained in step three, filter it with a microfiltration membrane with a pore size of 0.22μm, and collect the filtrate. Take the filtrate and use a Superdex TM 200 10/60 gel chromatography column for separation and purification. Connect the Superdex TM 20010/60 gel chromatography column to a fast protein liquid phase system, use 1×PBS buffer (pH 8.0) as the mobile phase, and the flow rate is 0.5mL/min. Collect the post-column solution with a retention volume of 18-20mL corresponding to the elution peak, which is the SaPD protein solution. The electrophoresis diagram of the SaPD protein solution is shown in Figure 3, with only one protein band, and it is consistent with the estimated molecular weight (about 33.2KD).

实施例3、预苯酸脱氢酶(SaPD蛋白)的酶学性质Example 3. Enzymatic properties of prephenate dehydrogenase (SaPD protein)

Tris-HCl缓冲液(100mM,pH 8.0):称取1.211g Tris,用去离子水溶解,用HCl调节pH至8.0,定容至1L。Tris-HCl buffer (100 mM, pH 8.0): Weigh 1.211 g Tris, dissolve it in deionized water, adjust the pH to 8.0 with HCl, and make up to 1 L.

5mM预苯酸溶液:称取0.018g预苯酸钡盐,用去离子水溶解,并定容至10mL。5 mM prephenic acid solution: weigh 0.018 g of barium prephenate salt, dissolve it in deionized water, and make up to 10 mL.

100mM EDTA:称取2.92g EDTA,用去离子水溶解,并定容至100mL。100mM EDTA: Weigh 2.92g EDTA, dissolve in deionized water, and make up to 100mL.

100mM DTT:称取1.54g DTT,用去离子水溶解,并定容至100mL。100mM DTT: Weigh 1.54g DTT, dissolve in deionized water, and make up to 100mL.

100mM NAD+:称取0.663g NAD+,用去离子水溶解,并定容至10mL。100mM NAD + : Weigh 0.663g NAD + , dissolve it in deionized water, and make up to 10mL.

酶促反应体系体积为1mL,含有50mM Tris(pH 8.0),1mmol/L EDTA,1mmol/L DTT,2mmol/L NAD+,0.5mM预苯酸。在设定好温度的水浴锅或金属浴中预热5min。The volume of the enzymatic reaction system is 1 mL, containing 50 mM Tris (pH 8.0), 1 mmol/L EDTA, 1 mmol/L DTT, 2 mmol/L NAD + , and 0.5 mM prephenic acid. Preheat in a water bath or metal bath set to a certain temperature for 5 minutes.

加入20μL粗酶液甲,混匀开始反应,计时20min。Add 20 μL of crude enzyme solution A, mix well to start the reaction, and time for 20 minutes.

加入500μL 1mol/L的NaOH溶液终止酶促反应,10000g离心10min,去除沉淀。在酶标仪中用96孔板测定OD340nm值。The enzymatic reaction was terminated by adding 500 μL of 1 mol/L NaOH solution, and the mixture was centrifuged at 10000 g for 10 min to remove the precipitate. The OD 340 nm value was measured using a 96-well plate in an ELISA reader.

一、pH对预苯酸脱氢酶活性的影响1. Effect of pH on the activity of prephenate dehydrogenase

1、最适pH1. Optimum pH

取实施例2制备的SaPD蛋白溶液,用缓冲液稀释至2倍体积,将稀释液作为供试液。The SaPD protein solution prepared in Example 2 was diluted to 2 times its volume with a buffer solution, and the dilution was used as the test solution.

分别采用如下缓冲液:pH 3.0的柠檬酸盐缓冲液、pH 4.0的柠檬酸盐缓冲液、pH5.0的柠檬酸盐缓冲液、pH 6.0的柠檬酸盐缓冲液、pH 6.0的磷酸盐缓冲液、pH 7.0的磷酸盐缓冲液、pH 8.0的磷酸盐缓冲液、pH 8.0的碳酸盐缓冲液、pH9.0的碳酸盐缓冲液、pH10.0的碳酸盐缓冲液、pH 11.0的碳酸盐缓冲液。柠檬酸盐缓冲液的配方见表2。磷酸盐缓冲液的配方见表3。各种盐缓冲液的配方见表4。The following buffers were used respectively: pH 3.0 citrate buffer, pH 4.0 citrate buffer, pH 5.0 citrate buffer, pH 6.0 citrate buffer, pH 6.0 phosphate buffer, pH 7.0 phosphate buffer, pH 8.0 phosphate buffer, pH 8.0 carbonate buffer, pH 9.0 carbonate buffer, pH 10.0 carbonate buffer, pH 11.0 carbonate buffer. The formula of the citrate buffer is shown in Table 2. The formula of the phosphate buffer is shown in Table 3. The formulas of various salt buffers are shown in Table 4.

表2Table 2

表3table 3

表4Table 4

2、SaPD蛋白的最适pH为8。将采用最适pH对应的缓冲液时的OD340nm值作为100%,计算采用各种缓冲液时的相对值,作为相对酶活。结果见图4。2. The optimum pH of SaPD protein is 8. The OD 340nm value when using the buffer corresponding to the optimum pH is taken as 100%, and the relative values when using various buffers are calculated as the relative enzyme activity. The results are shown in Figure 4.

二、温度对预苯酸脱氢酶活性的影响2. Effect of temperature on the activity of prephenate dehydrogenase

1、最适反应温度1. Optimum reaction temperature

取实施例2制备的SaPD蛋白溶液,用Tris-HCl缓冲液(100mM、pH 8.0)稀释至2倍体积,然后作为供试液。The SaPD protein solution prepared in Example 2 was diluted to twice its volume with Tris-HCl buffer (100 mM, pH 8.0) and then used as the test solution.

检测方法:反应总体积为1mL,含有50mM Tris(pH 8.0),1mmol/L EDTA,1mmol/LDTT,2mmol/L NAD+,0.5mM预苯酸的反应液,于20℃、30℃、40℃、50℃、60℃、70℃、80℃分别预热5min。加入供试液20μL,反应20min后,加入1mol/L的NaOH 100μL终止反应.于10000g离心10min,取上清液200μL,在酶标仪中用96孔板测定OD340nm值。Detection method: The total reaction volume is 1 mL, containing 50 mM Tris (pH 8.0), 1 mmol/L EDTA, 1 mmol/L DTT, 2 mmol/L NAD+, and 0.5 mM prephenic acid, and preheated at 20°C, 30°C, 40°C, 50°C, 60°C, 70°C, and 80°C for 5 min. Add 20 μL of the test solution, react for 20 min, and then add 100 μL of 1 mol/L NaOH to terminate the reaction. Centrifuge at 10000 g for 10 min, take 200 μL of the supernatant, and measure the OD 340nm value in a 96-well plate in an ELISA reader.

2、最适反应温度为40℃。将采用最适反应温度时的OD340nm值作为100%,计算采用各种反应温度时的相对值,作为相对酶活。结果见图5。2. The optimum reaction temperature is 40°C. The OD 340nm value at the optimum reaction temperature is taken as 100%, and the relative values at various reaction temperatures are calculated as the relative enzyme activity. The results are shown in Figure 5.

三、酶活力的测定3. Determination of enzyme activity

酶活(IU)定义为:在30℃和pH 7.0的情况下,每催化产生1mol NADH的酶量为一个酶活力单位U。Enzyme activity (IU) is defined as: at 30°C and pH 7.0, the amount of enzyme that catalyzes the production of 1 mol of NADH is one enzyme activity unit U.

检测方法:加入供试液20μL、50mM Tris(pH 8.0),1mmol/L EDTA,1mmol/L DTT,2mmol/L NAD+,0.5mM预苯酸,30℃反应10min,连续记录OD340nm数值。Detection method: Add 20 μL of test solution, 50 mM Tris (pH 8.0), 1 mmol/L EDTA, 1 mmol/L DTT, 2 mmol/L NAD+, 0.5 mM prephenic acid, react at 30 °C for 10 min, and continuously record the OD 340 nm value.

采用实施例2制备的粗酶液甲作为供试液,酶活为527U/mL。The crude enzyme solution A prepared in Example 2 was used as the test solution, and the enzyme activity was 527 U/mL.

采用实施例2制备的粗酶液乙作为供试液,酶活为0U/mL。The crude enzyme solution B prepared in Example 2 was used as the test solution, and the enzyme activity was 0 U/mL.

采用实施例2制备的SaPD蛋白溶液作为供试液,检测单位体积供试液的酶活。检测实施例2制备的SaPD蛋白溶液中的蛋白浓度。将单位体积供试液的酶活除以单位体积供试液的蛋白含量,得到蛋白比活力,数值为757U/mg。The SaPD protein solution prepared in Example 2 was used as the test solution to detect the enzyme activity per unit volume of the test solution. The protein concentration in the SaPD protein solution prepared in Example 2 was detected. The enzyme activity per unit volume of the test solution was divided by the protein content per unit volume of the test solution to obtain the protein specific activity, which was 757 U/mg.

实施例4、预苯酸脱氢酶(SaPD蛋白)对L-酪氨酸的耐受Example 4: Tolerance of SaPD to L-Tyrosine

取实施例2制备的SaPD蛋白溶液,用Tris-HCl缓冲液(100mM、pH8.0)稀释至2倍体积,作为供试液;The SaPD protein solution prepared in Example 2 was diluted to 2 times the volume with Tris-HCl buffer (100 mM, pH 8.0) as the test solution;

反应总体积为1mL,含有50mM Tris(pH 8.0),1mmol/L EDTA,1mmol/LDTT,2mmol/LNAD+,0.5mM预苯酸。分别加入浓度为0.01mM、0.1mM、1mM、5mM、10mM的L-酪氨酸The total reaction volume was 1 mL, containing 50 mM Tris (pH 8.0), 1 mmol/L EDTA, 1 mmol/L DTT, 2 mmol/L NAD+, and 0.5 mM prephenic acid. L-tyrosine was added at concentrations of 0.01 mM, 0.1 mM, 1 mM, 5 mM, and 10 mM, respectively.

在40℃的水浴锅或金属浴中预热5min。Preheat in a water bath or metal bath at 40°C for 5 min.

加入20μL供试液,混匀开始反应,计时20min。Add 20 μL of test solution, mix well to start the reaction, and time for 20 minutes.

加入500μL 1mol/L的NaOH溶液终止酶促反应,10000g离心10min,去除沉淀。在酶标仪中用96孔板测定OD340nm值。The enzymatic reaction was terminated by adding 500 μL of 1 mol/L NaOH solution, and the mixture was centrifuged at 10000 g for 10 min to remove the precipitate. The OD 340 nm value was measured using a 96-well plate in an ELISA reader.

以不加L-酪氨酸的OD340nm值作为100%,计算加入不同浓度L-酪氨酸时的相对值,作为相对酶活。结果见图6。The OD 340nm value without L-tyrosine was taken as 100%, and the relative values when different concentrations of L-tyrosine were added were calculated as the relative enzyme activity. The results are shown in FIG6 .

实施例5、预苯酸脱氢酶(SaPD蛋白)用于制备L-酪氨酸Example 5: Use of SaPD protein to prepare L-tyrosine

1、实验过程1. Experimental process

(1)取实施例2制备的SaPD蛋白溶液,用PBS缓冲液(100mM,pH8.0)稀释至500U/mL,作为供试液。(1) The SaPD protein solution prepared in Example 2 was diluted to 500 U/mL with PBS buffer (100 mM, pH 8.0) as the test solution.

(2)反应物总体积100mL,含有50mM Tris(pH 8.0),1mmol/L EDTA,1mmol/L DTT,2mmol/L NAD+,0.5mM预苯酸。反应温度40℃,搅拌速度150rpm,反应时间12h。(2) The total volume of the reaction was 100 mL, containing 50 mM Tris (pH 8.0), 1 mmol/L EDTA, 1 mmol/L DTT, 2 mmol/L NAD+, and 0.5 mM prephenic acid. The reaction temperature was 40°C, the stirring speed was 150 rpm, and the reaction time was 12 h.

(3)反应混合物加入天冬氨酸转氨酶,天冬氨酸,反应pH 8.0,反应温度40℃,搅拌速度150rpm,反应时间24h。反应结束后,加入醋酸重结晶,得到L-酪氨酸晶体。(3) Aspartate aminotransferase and aspartic acid were added to the reaction mixture, the reaction pH was 8.0, the reaction temperature was 40°C, the stirring speed was 150 rpm, and the reaction time was 24 h. After the reaction was completed, acetic acid was added for recrystallization to obtain L-tyrosine crystals.

(4)使用反相色谱对L-酪氨酸进行分析,使用ZorbaxSB-C18(4.6×150mm)柱,柱温20℃,流速0.5mL/min,流动相使用8.0mM醋酸钠溶液(pH 4.0):甲醇=4:1,检测波长230nm。(4) L-tyrosine was analyzed by reverse phase chromatography using a Zorbax SB-C18 (4.6×150 mm) column, a column temperature of 20° C., a flow rate of 0.5 mL/min, a mobile phase of 8.0 mM sodium acetate solution (pH 4.0): methanol = 4:1, and a detection wavelength of 230 nm.

2、预苯酸脱氢酶(SaPD蛋白)用于制备L-酪氨酸2. Prephenate dehydrogenase (SaPD protein) is used to produce L-tyrosine

反应结束后,经HPLC分析得知,L-酪氨酸的转化率可达90%,说明该酶在L-酪氨酸制备方面有较大的应用潜力。After the reaction, HPLC analysis showed that the conversion rate of L-tyrosine could reach 90%, indicating that the enzyme has great application potential in the preparation of L-tyrosine.

Claims (5)

1. The protein coded by the prephenate dehydrogenase gene is characterized in that the amino acid sequence is shown as a sequence 1 in a sequence table.
2. A gene encoding the protein of claim 1.
3. The gene of claim 2, wherein the nucleotide sequence of the gene is shown in sequence table 2.
4. A recombinant expression vector, expression cassette or recombinant microorganism comprising the gene of claim 2 or 3.
5. Use of the protein of claim 1 as prephenate dehydrogenase.
CN202310197550.6A 2023-03-03 2023-03-03 Prephenate dehydrogenase SaPD and its encoding gene and application Active CN116410942B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310197550.6A CN116410942B (en) 2023-03-03 2023-03-03 Prephenate dehydrogenase SaPD and its encoding gene and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310197550.6A CN116410942B (en) 2023-03-03 2023-03-03 Prephenate dehydrogenase SaPD and its encoding gene and application

Publications (2)

Publication Number Publication Date
CN116410942A CN116410942A (en) 2023-07-11
CN116410942B true CN116410942B (en) 2024-07-30

Family

ID=87058864

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310197550.6A Active CN116410942B (en) 2023-03-03 2023-03-03 Prephenate dehydrogenase SaPD and its encoding gene and application

Country Status (1)

Country Link
CN (1) CN116410942B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113308453A (en) * 2021-06-23 2021-08-27 中国石油大学(华东) Amidohydrolase SaAH, and coding gene and application thereof
CN113549609A (en) * 2021-06-07 2021-10-26 中国石油大学(华东) Carbonic anhydrase SaCA and coding gene and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2441346A1 (en) * 2001-03-22 2002-10-03 Meiji Seika Kaisha, Ltd. Transformants producing substance pf1022 derivatives, methods for producing the same, and novel biosynthesis genes
JP4665613B2 (en) * 2004-06-15 2011-04-06 味の素株式会社 L-tyrosine producing bacterium and method for producing L-tyrosine
CN113637650B (en) * 2021-06-16 2022-09-20 中国石油大学(华东) Alanine dehydrogenase SaAD and its encoding gene and application
CN113684192B (en) * 2021-06-16 2022-09-16 中国石油大学(华东) D-lactate dehydrogenase SaDLD and coding gene and application thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113549609A (en) * 2021-06-07 2021-10-26 中国石油大学(华东) Carbonic anhydrase SaCA and coding gene and application thereof
CN113308453A (en) * 2021-06-23 2021-08-27 中国石油大学(华东) Amidohydrolase SaAH, and coding gene and application thereof

Also Published As

Publication number Publication date
CN116410942A (en) 2023-07-11

Similar Documents

Publication Publication Date Title
CN103555608B (en) Quininone reductase and application thereof in asymmetric synthesis of (R)-3-quinuclidinol
US10787651B2 (en) Bradyrhizobium monooxygenase and use thereof for preparation of chiral sulfoxide
CN108795916B (en) A lysine decarboxylase mutant, its encoding gene and its expression and application
CN107686850B (en) Method for producing alpha-ketoglutaric acid by converting co-expression recombinant strain
CN113151201A (en) High-thermal-stability and high-activity isoeugenol monooxygenase mutant and application thereof
CN115595314A (en) Engineering bacterium for expressing aspartate dehydrogenase and method for producing vitamin B5 by fermentation
CN108949652B (en) Engineering bacterium and application thereof in producing caffeic acid
CN115772514B (en) Modification of the amino acid motif of a nitrile hydratase substrate channel for the preparation of cinnamamide
CN109777788B (en) A leucine dehydrogenase mutant and its application
CN108546697B (en) Enzyme method for preparing beta alanine
CN114685629B (en) Method for improving microbial conversion concentration of 5-hydroxytryptophan
CN116410942B (en) Prephenate dehydrogenase SaPD and its encoding gene and application
CN118956810A (en) PGK-C-A protein, method and application for increasing the yield of Nostoc polysaccharide
CN107299074B (en) Construction method and application of formate dehydrogenase engineering strain
WO2024197480A1 (en) Method for synthesizing dexketoprofen by using amidase
CN113061593B (en) L-malate dehydrogenase mutant and application thereof
CN113684192B (en) D-lactate dehydrogenase SaDLD and coding gene and application thereof
JP2025504067A (en) D-Amino acid oxidase and its use in the production of L-glufosinate or its intermediates
CN103923889A (en) Hyacinthin reductase mutant
CN108034644B (en) A kind of L-lactate dehydrogenase mutant with improved catalytic efficiency and construction method thereof
JP4489598B2 (en) D-aminoacylase
CN105969755A (en) Tyrosine decarboxylase mutant and gene and application thereof
CN115948358B (en) L-aspartic oxidase SaAO, and coding gene and application thereof
CN113215122B (en) Carbonyl reductase mutant and coding gene and application thereof
CN115247144B (en) Genetically engineered bacteria producing L-threo-3-hydroxyaspartic acid and its application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant